1. Exquisite selectivity of griselimycin extends to beta subunit of DNA polymerases from Gram-negative bacterial pathogens.
- Author
-
Fenwick MK, Pierce PG, Abendroth J, Barrett KF, Barrett LK, Bowatte K, Choi R, Chun I, Conrady DG, Craig JK, Dranow DM, Hammerson B, Higgins T, Lorimer DD, Lukat P, Mayclin SJ, Hewitt SN, Peng YP, Shanbhogue A, Smutney H, Stigliano MZZ, Tillery LM, Udell HS, Wallace EG, DeRocher AE, Phan IQ, Staker BL, Subramanian S, Van Voorhis WC, Blankenfeldt W, Müller R, Edwards TE, and Myler PJ
- Subjects
- Gram-Negative Bacteria drug effects, Gram-Negative Bacteria enzymology, Gram-Negative Bacteria genetics, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemistry, Bacterial Proteins metabolism, Bacterial Proteins chemistry, Bacterial Proteins genetics, Bacterial Proteins antagonists & inhibitors, Models, Molecular, Crystallography, X-Ray, DNA Polymerase III metabolism, DNA Polymerase III chemistry, DNA Polymerase III antagonists & inhibitors, DNA Polymerase III genetics
- Abstract
Griselimycin, a cyclic depsidecapeptide produced by Streptomyces griseus, is a promising lead inhibitor of the sliding clamp component of bacterial DNA polymerases (β-subunit of Escherichia coli DNA pol III). It was previously shown to inhibit the Mycobacterium tuberculosis β-clamp with remarkably high affinity and selectivity - the peptide lacks any interaction with the human sliding clamp. Here, we used a structural genomics approach to address the prospect of broader-spectrum inhibition, in particular of β-clamps from Gram-negative bacterial targets. Fifteen crystal structures of β-clamp orthologs were solved, most from Gram-negative bacteria, including eight cocrystal structures with griselimycin. The ensemble of structures samples widely diverse β-clamp architectures and reveals unique protein-ligand interactions with varying degrees of complementarity. Although griselimycin clearly co-evolved with Gram-positive β-clamps, binding affinity measurements demonstrate that the high selectivity observed previously extends to the Gram-negative orthologs, with K
D values ranging from 7 to 496 nM for the wild-type orthologs considered. The collective results should aid future structure-guided development of peptide antibiotics against β-clamp proteins of a wide variety of bacterial targets., Competing Interests: Competing interests: The authors declare no competing interests., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF